With our in-house expertise in production, quality and medical affairs for Pharmaceutical/Biotech/Medical Device/Food companies, Authorities and Hospitals we are able to take a holistic view of our customer requirements, which differentiates us from others with respect to quality, speed and timelines. Our internal expertise covers
- interim management
- project management
- business & process review
- people management and many other competencies.
Dr. Miriam Rothenburger
Managing Director
Zug-Switzerland
miriam.rothenburger@prudentia-consult.com
Phone: +41 76 466 78 18
Miriam Rothenburger is a senior pharma leader with more than 20 years of work experience in the Pharmaceutical/Biotech/CMO-Industry. She offers an excellent track record in leadership, operational excellence and organisational development. Miriam has held several senior management positions in various global companies, e.g. Schering (now Bayer) Novartis, Boehringer Ingelheim, Hexal, Fresenius Kabi, Biotest and Aenova. She is a change driven player with a strong strategic mindset and high compliance standards who brings a lot of passion in day-to-day working.
Miriam`s functional experience focuses on leadership, production and process management, supply chain, improvement projects, inspection readiness, and other projects covering several pharmaceutical technologies (aseptic/liquids/solids/biotech/cell & gene/bulk production/packaging). Her expertise also covers quality affairs, training as well as coaching.
Miriam is a pharmacist and holds a PhD degree from Institute of Pharmacology & Toxicology, Technical University of Brunswik, Germany.
Miriam is founder of Prudentia Consulting GmbH and serves as managing director responsible for interim management, project, change and people management, production review, analysis & strategy and quality affairs.
Prof. Dr. Markus Rothenburger
Managing Director
Zug-Switzerland
markus.rothenburger@prudentia-consult.com
Phone: +41 79 790 84 55
Markus Rothenburger is a senior executive and medical professional with more than 25 years of clinical, medical & regulatory affairs, project management, strategy, KOL management and leadership experience. Markus has held senior management positions in several Hospitals (e.g. Central Military Hospital Koblenz, Westphalian Wilhelms University of Muenster), as well as executive roles in pharmaceutical and Biotech industries, e.g. Novartis, Fresenius Kabi, Biotest AG and Mallinckrodt Pharmaceuticals. He is highly skilled in the end to end delivery of value-added commercial solutions / process improvements from the Medical Affairs point of view; coordinating and developing high performance strategy in order to meet and exceed key global commercial and clinical objectives. He has managed multiple projects, conducted product launches and relaunches, published over 100 peer reviewed articles, built a reliable global key opinion leader network, cultivated excellent teaching skills, and gained broad experience in different cultures, working cross-functionally and in global teams. His expertise covers several disease areas such as immunology, oncology, hematology, cardiovascular, transplantation, sepsis, trauma, rheumatology, nutrition, critical care, burn, hepatology and gastroenterology.